ArticleScientific reports2018

PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer.

Chitra Risnayanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.